Myers Chen, Kayla V. http://orcid.org/0000-0002-0748-1092
de Groot, Amber E.
Mendez, Sabrina A.
Mallin, Mikaela M.
Amend, Sarah R.
Pienta, Kenneth J.
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-20-1-0353)
Patrick C. Walsh Prostate Cancer Research Fund
NCI (U54CA143803, CA163124, CA093900, CA143055)
William and Carolyn Stutt Research Fund
Ronald Rose
MC Dean, Inc
Mary and Dave Stevens
Louis Dorfman
Jones Family Foundation
Timothy Hanson
David and June Trone Family Foundation
Article History
Received: 7 May 2023
Accepted: 10 August 2023
First Online: 29 August 2023
Declarations
:
: Kenneth J. Pienta is a consultant for CUE Biopharma, Inc., is a founder and holds equity interest in Keystone Biopharma, Inc., and is an editor for Medical Oncology. Sarah R. Amend holds equity interest in Keystone Biopharma, Inc., and is an editor for Medical Oncology. All other authors have no relevant financial or non-financial interests to disclose.
: The Johns Hopkins Institutional Animal Care and Use Committee approved all experiments involving mice (protocol numbers MO19M41 and MO21M471).